15 September 2025
A cost-utility and budget impact analysis of the sunitinib risk-sharing scheme for the treatment of metastatic RCC and for advanced GIST after failure of imatinib
View Count
83
Share this research
Project Code
11-3-089-2557(1)
Country
Thailand
Project Duration
Start : 17 November 2014
End : 17 November 2014
End : 17 November 2014
Research Status
Completed 100%
Complete Research Report
Quantity 0 files
Download Count
0 times
15 September 2025
A cost-utility and budget impact analysis of the sunitinib risk-sharing scheme for the treatment of metastatic RCC and for advanced GIST after failure of imatinib
Research Type
Others
Related Technologies
Pharmaceuticals
Funding Source
National Health Security Office (NHSO)
Keyword / Search / TAG
Research Team
Principal Researcher
Co-Researcher
Related Organizations/
Supporting Organizations
National Health Security Office (NHSO)